Editas医药 EDIT 深 沪
交易中 07-31 11:25:25 美东时间
2.515
-0.005
-0.20%
华盛通- 最 高2.55
- 今 开2.49
- 成交量 68.45万股
- 最 低 2.40
- 昨 收 2.52
- 总市值 2.11亿
- 52周最高 4.19
- 市盈率 静 --
- 换手率 0.82%
- 52周最低 0.9101
- 委 比 -64.52%
- 总股本 8371.29万
- 历史最高 99.95
- 量 比 1.12
- 振 幅 5.95%
- 历史最低 0.9101
- 每 手 1
- 风险率 2.29%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多POLARIS INTRODUCES THE ALL-NEW RANGER 500, STARTING AT UNDER $10,000
Built to deliver value and versatility to help make outdoor chores easier MINNEAPOLIS, July 29, 2025 /PRNewswire/ -- Polaris Off Road, the world leader in powersports and off-road innovation...
07-30 03:31
Berkshire Hills Reports Strong Earnings Growth
Second Quarter 2025 GAAP EPS $0.66; Operating EPS $0.69 15% increase in operating EPS linked quarter; 25% increase year-over-year 3% increase in operating revenue linked quarter, 2% decrease...
07-24 19:30
Catalyst Bancorp, Inc. Announces 2025 Second Quarter Results
OPELOUSAS, La., July 24, 2025 /PRNewswire/ -- Catalyst Bancorp, Inc. (Nasdaq: "CLST") (the "Company"), the parent company for Catalyst Bank (the "Bank") (www.catalystbank.com), reported net ...
07-24 19:00
Luxury Group by Marriott International Unveils Luxury Wellbeing Series 2025
An enriching wellness escapade across Asia-Pacific that revitalizes the mind, body and spirit. SINGAPORE, July 17, 2025 /PRNewswire/ -- As the allure for wellness-centric luxury travel conti...
07-17 20:00
CEL-SCI announces pricing of $5.7 million offering
CEL-SCI (NYSE:CVM) announced on Friday the pricing of a best-efforts offering of 1,500,000 shares of its common stock. Each share of common stock is being sold at an offering price of $3.82 per share,...
07-12 03:04
PEPSI-COLA® AND SAMII RYAN® LAUNCH LIMITED-EDITION PEPSI® WILD CHERRY CAPSULE, BLENDING RODEO-INSPIRED FASHION WITH ICONIC FLAVOR
LOS ANGELES, July 11, 2025 /PRNewswire/ -- PepsiCo (NASDAQ: PEP) is saddling up for summer with the launch of an exclusive collaboration with renowned streetwear brand Samii Ryan®. The Pepsi...
07-12 00:07
Nektar Therapeutics surge continues as stock up another 25%
Nektar Therapeutics (NASDAQ:NKTR), which closed Tuesday up ~156% after its lead asset, rezpegaldesleukin, met its main goal in a mid-stage trial for atopic dermatitis, also known as eczema, is up anot...
06-26 02:14
FDA细胞与基因治疗监管层集体停职 基因编辑股再遭冲击
智通财经注意到，周五美股盘初，基因编辑公司股价整体持稳，随后随大盘下跌。此前美国FDA生物制品评价与研究中心(CBER)再次突发人事变动——继年初前主任彼得·马...
06-20 21:57
Gene editors steady despite latest leadership shake-up at FDA
Shares of gene editing companies were largely steady in the premarket on Friday after the FDA’s Center for Biologics Research and Evaluation (CBER) faced another abrupt leadership transition following...
06-20 20:39
超93亿！基因治疗企业溢价113%卖出
（转自：动脉新医药） 当地时间2025年 6月17日，礼来正式宣布收购总部位于波士顿的临床阶段公司 Verve Therapeutics，Inc.（纳斯达克代码...
06-18 17:00
